Nuvectis Pharma Inc (NVCT)
8.14
+1.38
(+20.41%)
USD |
NASDAQ |
May 03, 16:00
8.145
0.00 (0.00%)
Pre-Market: 20:00
Nuvectis Pharma Price to Book Value: 11.85 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 11.85 |
| May 02, 2024 | 9.845 |
| May 01, 2024 | 9.685 |
| April 30, 2024 | 8.854 |
| April 29, 2024 | 9.291 |
| April 26, 2024 | 9.466 |
| April 25, 2024 | 9.481 |
| April 24, 2024 | 9.772 |
| April 23, 2024 | 9.597 |
| April 22, 2024 | 10.34 |
| April 19, 2024 | 9.932 |
| April 18, 2024 | 9.787 |
| April 17, 2024 | 9.845 |
| April 16, 2024 | 10.17 |
| April 15, 2024 | 9.335 |
| April 12, 2024 | 10.22 |
| April 11, 2024 | 10.81 |
| April 10, 2024 | 10.73 |
| April 09, 2024 | 11.20 |
| April 08, 2024 | 11.37 |
| April 05, 2024 | 11.33 |
| April 04, 2024 | 11.23 |
| April 03, 2024 | 12.01 |
| April 02, 2024 | 11.56 |
| April 01, 2024 | 11.55 |
| Date | Value |
|---|---|
| March 28, 2024 | 11.94 |
| March 27, 2024 | 12.15 |
| March 26, 2024 | 12.01 |
| March 25, 2024 | 12.95 |
| March 22, 2024 | 13.14 |
| March 21, 2024 | 13.18 |
| March 20, 2024 | 12.74 |
| March 19, 2024 | 12.77 |
| March 18, 2024 | 15.22 |
| March 15, 2024 | 16.02 |
| March 14, 2024 | 13.33 |
| March 13, 2024 | 14.04 |
| March 12, 2024 | 14.39 |
| March 11, 2024 | 14.78 |
| March 08, 2024 | 14.94 |
| March 07, 2024 | 14.80 |
| March 06, 2024 | 14.33 |
| March 05, 2024 | 14.85 |
| March 04, 2024 | 15.00 |
| March 01, 2024 | 15.58 |
| February 29, 2024 | 14.09 |
| February 28, 2024 | 14.03 |
| February 27, 2024 | 13.95 |
| February 26, 2024 | 13.23 |
| February 23, 2024 | 10.74 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.463
Minimum
Nov 03 2022
24.00
Maximum
Jun 13 2023
11.44
Average
10.85
Median
Price to Book Value Benchmarks
| Schrodinger Inc | 3.350 |
| CEL-SCI Corp | 6.955 |
| AIM ImmunoTech Inc | 2.116 |
| IGC Pharma Inc | 3.599 |
| NovaBay Pharmaceuticals Inc | 2.094 |
Price to Book Value Related Metrics
| Price | 8.14 |
| Earnings Yield | -17.57% |
| Market Cap | 144.64M |